Comparison

IRAK-4 Antibody

Item no. PRS-3125-0.02mg
Manufacturer ProSci
Amount 0.02 mg
Quantity options 0.02 mg 0.1 mg
Category
Type Antibody Polyclonal
Format Liquid
Applications WB, IF, ICC, ELISA
Specific against Human (Homo sapiens)
Host Rabbit
Isotype IgG
Conjugate/Tag Unconjugated
Citations Cao et al. Science 1996; 271:1128-31
Muzio et al. Science 1997; 278:1612-5.
Wesche et al. J. Biol. Chem. 1999; 274:19403-10.
Li et al. Proc. Natl. Acad. Sci. USA 2002; 99:5567-72.
Koziczak-Holbro et al. IRAK-4 kinase activity-dependent and -independent regulation of lipopolysaccharide-inducible genes. Eur J Immunol. 2008;38(3):788-96.PMID: 18266302
Hatao et al. Prolonged Toll-like receptor stimulation leads to down-regulation of IRAK-4 protein. J Leukoc Biol. 2004;76(4):904-8. PMID: 15258191
Heinz et al. The death domain-containing protein Unc5CL is a novel MyD88-independent activator of the pro-inflammatory IRAK signaling cascade. Cell Death Differ. 2012;19(4):722-31. PMID: 22158417
Koziczak-Holbro et al. IRAK-4 kinase activity is required for interleukin-1 (IL-1)receptor- and toll-like receptor 7-mediated signaling and gene expression. J Biol Chem. 2007;282(18):13552-60. PMID: 17337443
NCBI IRAK4
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias IRAK-4 Antibody: IPD1,REN64,IRAK-4,NY-REN-64,Interleukin-1 receptor-associated kinase 4,Renal carcinoma antigen NY-REN-64
Shipping Condition Cool pack
Available
Manufacturer - Type
Primary Antibodies
Shipping Temperature
Blue Ice
Storage Conditions
IRAK-4 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Molecular Weight
Predicted: 52kD
Observed: 55 kD
Manufacturer - Research Area
Signal Transduction,
Background
IRAK-4 Antibody: Interleukin-1 (IL-1) and lipopolysaccharide (LPS) induces cellular responses through IL-1 receptor (IL-1R) and Toll-like receptors (TLR). IL-1R-associated kinases (IRAK, IRAK2, and IRAK-M) regulate the activation of NF-κ B and MAP kinase (MAPK) by IL-1R/TLR. A novel member in the IRAK/Pelle family was recently identified and designated IRAK-4. Overexpression of IRAK-4 activates NF-κ B and MAPK pathways. IRAK-4 interacts with and phosphorylates IRAK-1. IRAK-4-deficient animals are completely resistant to the challenge with LPS. Animals and humans lacking IRAK-4 are impaired in their responses to viral and bacterial challenges. Members in IRAK/Pelle family play a central role in IL-1R/TLR mediated inflammatory responses and in innate immunity.
By Type
Signal Transduction,
Badges
Trial Size, IAV, Cell Treatment
Modifications
None
Protein Gi #
20219010
Purification
IRAK-4 Antibody is affinity chromatography purified via peptide column.
Isoforms
Human IRAK4 has 2 isoforms, including isoform 1 (460aa, 52kD) and isoform 2 (336aa, 38kD). Mouse IRAK4 has one isoform (459aa, 51kD) and Rat IRAK4 also has one isoform (461aa, 51kD). 3125 can detect human isoforms as well as mouse and rat IRAK4.
Validation

Independent Antibody Validation in Cell lines (Figure 2) shows similar IRAK4 expression profile in human cell lines detected by two independent anti-IRAK4 antibodies that recognize different epitopes, 3125 against C-terminus domain and 24-025 against recombinant fusion protein. IRAK4 proteins are detected in the most tested cell lines at different expression levels by the two independent antibodies.


KO validation (Figure 6): Anti-IRAK4 antibody (3125) specificity was further verified by IRAK4 knockout and mutant mice. IRAK4 signal in the macrophages of IRAK KO mice and mutant mice was disrupted as compared to wild type mice.


Regulated expression validation (Figure 7): IRAK4 expression detected by anit-IRAK4 antibodies (3125) was reduced with CSK-4 treatment, which was rescued by proteasome inhibitors.


KD validation (Figure 8): Anti-IRAK4 antibody (3125) specificity was further verified by IRAK4 knockdown. IRAK4 signal was disrupted in HEK293T cells transfected with IRAK4 siRNAs.


Positive Control 1
Positive Control 2
Positive Control 3
Positive Control 5
Concentration
1 mg/mL
Buffer
IRAK-4 Antibody is supplied in PBS containing 0.02% sodium azide.
Application Note
WB: 1-4 μ g/mL; ICC: 10 μ g/mL; IF: 10 μ g/mL.
Antibody validated: Western Blot in human samples; Immunocytochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.
Homology
Predicted species reactivity based on immunogen sequence: Bovine: (85%), Mouse: (85%), Rat (77%)
Manufacturer - Specificity
IRAK-4 antibody is predicted to not cross-react with other members of the IRAK protein family.
Immunogen
Anti-IRAK4 antibody (3125) was raised against a peptide corresponding to 13 amino acids near the carboxy terminus of human IRAK4.

The immunogen is located within the last 50 amino acids of IRAK4.
Clonality
Polyclonal
NCBI Official Name
interleukin-1 receptor-associated kinase 4
NCBI Organism
Homo sapiens
Disclaimer
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
User Note
Optimal dilutions for each application to be determined by the researcher.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.02 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close